Загрузка...
A comparison of subgroup identification methods in clinical drug development: Simulation study and regulatory considerations
With advancement of technologies such as genomic sequencing, predictive biomarkers have become a useful tool for the development of personalized medicine. Predictive biomarkers can be used to select subsets of patients, which are most likely to benefit from a treatment. A number of approaches for su...
Сохранить в:
| Опубликовано в: : | Pharm Stat |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6772173/ https://ncbi.nlm.nih.gov/pubmed/31270933 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pst.1951 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|